Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...
Accumulation of clots causes some of the most severe symptoms of sickle cell disease, including strokes, kidney failure, ...
Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...
Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...
A GROUNDBREAKING genetic treatment with the potential to cure sickle cell disease will be rolled out on the NHS. The one-off ...
People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...
People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...
On Hump Day, investors piled into CRISPR Therapeutics (NASDAQ: CRSP) stock, sending its price more than 9% higher at the ...
NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...
This switches to the adult form once they are born. Crucially foetal haemoglobin is not affected by sickle cell disease, so ...
Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr ... for certain patients with severe sickle cell disease. Here patients have reacted to ...
Some with severe sickle cell disease in England will now be able to access landmark CRISPR gene editing therapy, according to new health guidelines which were hailed as marking a “significant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results